DE602005012597D1 - Verfahren zur herstellung optisch aktiver n-carbamat-geschützter beta-lactame durch optische auflösung unter verwendung einer candida antarctica lipase - Google Patents

Verfahren zur herstellung optisch aktiver n-carbamat-geschützter beta-lactame durch optische auflösung unter verwendung einer candida antarctica lipase

Info

Publication number
DE602005012597D1
DE602005012597D1 DE602005012597T DE602005012597T DE602005012597D1 DE 602005012597 D1 DE602005012597 D1 DE 602005012597D1 DE 602005012597 T DE602005012597 T DE 602005012597T DE 602005012597 T DE602005012597 T DE 602005012597T DE 602005012597 D1 DE602005012597 D1 DE 602005012597D1
Authority
DE
Germany
Prior art keywords
carbamate
candida antarctica
lactame
production
optically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005012597T
Other languages
German (de)
English (en)
Inventor
Ankush Argade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rigel Pharmaceuticals Inc
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of DE602005012597D1 publication Critical patent/DE602005012597D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602005012597T 2004-11-15 2005-11-15 Verfahren zur herstellung optisch aktiver n-carbamat-geschützter beta-lactame durch optische auflösung unter verwendung einer candida antarctica lipase Expired - Lifetime DE602005012597D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62840104P 2004-11-15 2004-11-15
PCT/US2005/041276 WO2006055528A2 (en) 2004-11-15 2005-11-15 Process for the preparation of an optically acitive n-carbamate protected beta-lactam by optical resolution employing a candida antarctica lipase

Publications (1)

Publication Number Publication Date
DE602005012597D1 true DE602005012597D1 (de) 2009-03-19

Family

ID=36190809

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005012597T Expired - Lifetime DE602005012597D1 (de) 2004-11-15 2005-11-15 Verfahren zur herstellung optisch aktiver n-carbamat-geschützter beta-lactame durch optische auflösung unter verwendung einer candida antarctica lipase

Country Status (10)

Country Link
US (1) US7459301B2 (cg-RX-API-DMAC7.html)
EP (1) EP1812581B1 (cg-RX-API-DMAC7.html)
JP (1) JP4738416B2 (cg-RX-API-DMAC7.html)
AT (1) ATE421996T1 (cg-RX-API-DMAC7.html)
CA (1) CA2580151C (cg-RX-API-DMAC7.html)
DE (1) DE602005012597D1 (cg-RX-API-DMAC7.html)
DK (1) DK1812581T3 (cg-RX-API-DMAC7.html)
ES (1) ES2320364T3 (cg-RX-API-DMAC7.html)
PT (1) PT1812581E (cg-RX-API-DMAC7.html)
WO (1) WO2006055528A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4812763B2 (ja) * 2004-05-18 2011-11-09 ライジェル ファーマシューティカルズ, インコーポレイテッド シクロアルキル置換ピリミジンジアミン化合物およびそれらの用途
GB2420559B (en) * 2004-11-15 2008-08-06 Rigel Pharmaceuticals Inc Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
EP1960372B1 (en) 2005-12-15 2015-12-09 Rigel Pharmaceuticals, Inc. Kinase inhibitors and their uses
HU227663B1 (en) * 2007-07-09 2011-10-28 Univ Szegedi Resolution process
CN102264368B (zh) 2008-12-22 2014-09-10 米伦纽姆医药公司 极光激酶抑制剂与抗cd20抗体的组合
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors
US10335494B2 (en) 2013-12-06 2019-07-02 Millennium Pharmaceuticals, Inc. Combination of aurora kinase inhibitors and anti-CD30 antibodies
EP3324976A4 (en) 2015-07-21 2019-03-27 Millennium Pharmaceuticals, Inc. ADMINISTRATION OF KINASE AURORA INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
WO2019195658A1 (en) 2018-04-05 2019-10-10 Dana-Farber Cancer Institute, Inc. Sting levels as a biomarker for cancer immunotherapy
WO2019201279A1 (zh) * 2018-04-18 2019-10-24 广东东阳光药业有限公司 一种桥环化合物的制备方法
WO2021041532A1 (en) 2019-08-26 2021-03-04 Dana-Farber Cancer Institute, Inc. Use of heparin to promote type 1 interferon signaling

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE258605T1 (de) * 1998-07-09 2004-02-15 Lonza Ag Verfahren zur herstellung von (1r,4s)-2- azabicyclo 2.2.1 hept-5-en-3-on-derivaten

Also Published As

Publication number Publication date
EP1812581B1 (en) 2009-01-28
WO2006055528A3 (en) 2006-08-31
EP1812581A2 (en) 2007-08-01
JP2008520206A (ja) 2008-06-19
US20060166308A1 (en) 2006-07-27
CA2580151A1 (en) 2006-05-26
JP4738416B2 (ja) 2011-08-03
WO2006055528A2 (en) 2006-05-26
PT1812581E (pt) 2009-04-22
ES2320364T3 (es) 2009-05-21
CA2580151C (en) 2014-02-04
US7459301B2 (en) 2008-12-02
DK1812581T3 (da) 2009-05-11
ATE421996T1 (de) 2009-02-15

Similar Documents

Publication Publication Date Title
Faber et al. Selectivity-enhancement of hydrolase reactions
ATE421996T1 (de) Verfahren zur herstellung optisch aktiver n- carbamat-geschützter beta-lactame durch optische auflösung unter verwendung einer candida antarctica lipase
ATE474910T1 (de) L-glutaminsäure produzierender mikroorganismus sowie verfahren zur produktion von l- glutaminsäure
DE602004023389D1 (de) Verfahren zur herstellung von uv-härtbaren dichtungsanordnungen
DE69914458D1 (de) Verfahren zur enzymatischen auflösung von laktamen
ATE452186T1 (de) Cephalosporin-c-acylase-mutante und verfahren zur herstellung von 7-aca damit
ATE553210T1 (de) Verfahren zur herstellung von l-threonin unter verwendung eines mikroorganismus mit inaktivierten galr gen.
ATE484575T1 (de) Mikroorganismus des genus corynebacterium der eine erhöhte l-lysinproduktivität hat und verfahren zur herstellung von l-lysin durch besagten mikroorganismus
ATE470657T1 (de) Verfahren zur herstellung von isocyanaten
ATE488597T1 (de) Verfahren zur herstellung optisch aktiver aminosäuren unter verwendung eines ganzzellenkatalysators
ATE283348T1 (de) Verfahren zur herstellung von aminoalkoholen und derivaten davon
ATE459723T1 (de) Verfahren zur herstellung von (4s)-3,4-dihydroxy- 2,6,6-trimethyl-cyclohex-2-enon und derivaten davon unter verwendung der azoarcus phenylethanol dehydrogenase
ATE134610T1 (de) Verfahren zur herstellung von optisch aktiven 4- amino-3-hydroxycarbonsäuren
ATE332391T1 (de) Verfahren zur enzymatischen herstellung enantiomerenangereicherter beta-aminosäuren
Kume et al. Enzyme-mediated enantioface-differentiating hydrolysis of α-substituted sulfur-containing cyclic ketone enol esters
EP1367129A3 (de) Verfahren zur enzymatischen Herstellung enantiomerenangereicherter Beta-Aminosäuren
DE60128461D1 (de) Verfahren zur herstellung von optisch aktiven beta-amino alkoholen
ATE176931T1 (de) Verfahren zur enzymatischen herstellung von optisch aktiven estern einer transglycidsäure
TW200621989A (en) A method for the preparation of mycophenolate mofetil by enzymatic transesterification
ATE312197T1 (de) Verfahren zur enantioselektiven herstellung von sekundären alkoholen durch lipasenkatalysierte solvolyse der korrespondierenden acetessigester
ATE442452T1 (de) Verfahren zur herstellung von beta-hydroxy- aminosäuren und dafür geeignetes enzym
ATE326545T1 (de) Verfahren zur herstellung von d- oder l-menthol
ATE304606T1 (de) Verfahren zur enzymatischen herstellung von enantiomerenreinen 1,3-dioxolan-4-on- und 1,3- oxathiolan-5-on-derivaten
ATE386132T1 (de) Verfahren zur enantioselektiven öffnung von 3- substituierten oxetan-2-onen unter verwendung der lipasen von candida antarctica oder von burkholderia plantarii
BR9810472B1 (pt) processos para a preparação de (1r,4s)-2-aza-biciclo[2.2.1]hept-5-en-3-ona n-protegida substancialmente enaciomericamente pura e para a resolução enanciomérica de uma mistura racêmica de (±) 2-aza-biciclo[2.2.1]hept-5-en-3-ona n-protegida.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition